TP53 and neoplasm: While outside the scope of this study, a comprehensive investigation into the role of tumor immune cells in the cytokine dependency switch and phenotypes driven by gain/loss-of-function TP53 mutations may yield further insights for putative combination therapies targeting TP53-mutant GC.